p73, a member of the p53 tumor suppressor family, is involved in the DNA damage response and serves as a mediator of p53 tumor suppression. Like p53, p73 is a sequence-specific DNA-binding transcription factor and an important regulator in the control of the cell cycle and apoptosis, p73 is expressed as three major variants, TA, DN, and DTA. The TA variant is transcribed from the upstream promoter and produces at least seven alternatively spliced TA isoforms (p73a-h), which differ in their carboxyl termini. The DN variant is transcribed from an alternate promoter in intron 3 and similarly produces at least another seven alternatively spliced DN isoforms (DNp73a-h). Since the N-terminal activation domain is absent in the DN variant, it is hypothesized that the DN variant is transcriptionally inactive and potentially dominant negative over the TA variant and possibly over p53. Interestingly, we have found and, later several other groups have confirmed, that the DN variant of the p53 family member p63, which also lacks the N-terminal activation domain, is transcriptionally active and capable of inducing specific target genes. Thus, we hypothesize that DNp73 is transcriptionally active and exerts its function by regulating specific target genes. Since p73 is 63% identical in amino acid to p53 in the DNA-binding domain, it can regulate some p53 target genes, presumably via the p53 responsive element. However, we found that the functional domains in p73 are different from that in p53. We also found that while p73 regulates IGFBP3 and GADD45, it does not regulates a luciferase reporter under the control of the p53 responsive element found in both genes. Thus, we hypothesize that p73 regulates some target genes through its unique responsive element. These hypotheses will be addressed in three aims: (1) to analyze the activity of the DN variant of p73, (2) to determine the mechanism by which various p73 isoforms differentially regulate IGFBP3 and GADD45, and (3) to determine the role of IGFBP3 and GADD45 in mediating p73 function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA081237-08
Application #
6850829
Study Section
Special Emphasis Panel (ZRG1-PTHB (04))
Program Officer
Blair, Donald G
Project Start
1999-05-01
Project End
2009-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
8
Fiscal Year
2005
Total Cost
$293,625
Indirect Cost
Name
University of Alabama Birmingham
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Zhang, Jin; Chen, Xinbin (2018) p53 tumor suppressor and iron homeostasis. FEBS J :
Zhang, Jin; Lucchesi, Christopher; Chen, Xinbin (2016) A new function for p53 tetramerization domain in cell fate control. Cell Cycle 15:2854-2855
Ren, Cong; Zhang, Jin; Yan, Wensheng et al. (2016) RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense. J Biol Chem 291:9629-37
Wang, Junjian; Wang, Haibin; Wang, Ling-Yu et al. (2016) Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy. Cell Death Differ 23:1886-1896
Lucchesi, Chris; Zhang, Jin; Chen, Xinbin (2016) Modulation of the p53 family network by RNA-binding proteins. Transl Cancer Res 5:676-684
Yan, Wensheng; Scoumanne, Ariane; Jung, Yong-Sam et al. (2016) Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation. Genes Dev 30:522-34
Zhang, Min; Zhang, Jin; Yan, Wensheng et al. (2016) p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability. Oncotarget 7:78255-78268
Zhang, M; Xu, E; Zhang, J et al. (2015) PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38. Oncogene 34:5900-11
Cho, Seong-Jun; Teng, I-Fang; Zhang, Min et al. (2015) Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation. Oncotarget 6:305-16
Zhang, Yanhong; Young, Ashley; Zhang, Jin et al. (2015) P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition. Oncotarget 6:13994-4004

Showing the most recent 10 out of 72 publications